|
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants |
University of Washington, Seattle |
The RUNX1 Research Program |
|
Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond |
Albert Einstein College of Medicine |
The RUNX1 Research Program |
|
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
|
Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells |
Children’s Hospital of Pittsburgh |
Northwestern Mutual Foundation |
|
Investigating Epigenetic Mechanisms of Response to Allogenic CAR T Cell Therapy |
St. Jude Children’s Research Hospital |
Ava's Army |
|
Characterizing Inflammatory Phenotypes Associated with RUNX1 Deficiency |
Dana-Farber Cancer Institute |
The RUNX1 Research Program |
|
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders |
The Regents of the University of California San Francisco |
The RUNX1 Research Program |
|
Dissecting and Targeting Apoptotic Resistance in Pediatric Leukemia |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Isogenic Models of Pediatric AML for Interrogating Different RAS Pathway Mutations |
University of California San Francisco |
Northwestern Mutual Foundation |
